Read the latest news from regional and global sources, presenting different voices and perspectives.
Deja Vu? Colorado’s Special Session Ends with Budget Tweaks, But Again No Long-Term AI Deal
JD Supra - California
·
August 28, 2025
Last Thursday, Aug. 21, the Colorado General Assembly reconvened for its 2025 Extraordinary Session, mostly focused on addressing the $750‒$800 million state budget shortfall created by the federal government’s passage of the One Big Beautiful...
How to get healthcare in Spain as a tourist
The Local - Spain
·
August 7, 2025
If you're coming on holiday to Spain this summer, here's what you need to know about accessing healthcare in an emergency. It’s the height of tourist season right now in Spain, like much of the rest of Europe, and while no one likes to think about...
EU approves new twice-yearly HIV prevention jab
Euronews
·
August 26, 2025
Published on 26/08/2025 - 14:57 GMT+2 •Updated 28/08/2025 - 14:42 GMT+2 The European Commission has formally approved a twice-yearly injection to prevent HIV, clearing the way for the jab to be rolled out across the European Union, according to...
European Commission Grants Marketing Authorization for Aflibercept Biosimilar Mynzepli
Ophthalmology Breaking News
·
August 25, 2025
Advanz Pharma and Alvotech have announced that the European Commission (EC) has granted marketing authorization for Mynzepli (formerly AVT06), a biosimilar to aflibercept (Eylea; Bayer and Regeneron). The approval allows Mynzepli to be marketed...
Lessons for Guyana from Liechtenstein
Stabroek News
·
August 3, 2025
Dear Editor, Early on Friday morning, August 1, 2025 – notably Switzerland’s National Day – there was a rude awakening for the Federal Council, Parliament, and the public. President Trump imposed a new punitive tariff of 39% on Swiss exports to...
What the Colorado legislature did during its special session to tackle a $750M budget hole
The Colorado Sun
·
August 27, 2025
Democratic state lawmakers voted this week to increase the tax bills of Colorado businesses and business owners by about $150 million to help close a roughly $750 million hole in the state budget. But they deferred to the governor for perhaps the...
Gilead Sciences gets European Commission marketing authorization for twice yearly Yeytuo for HIV prevention
Medical Dialogues
·
August 27, 2025
Foster City: Gilead Sciences, Inc. has received the European Commission (EC) marketing authorization for Yeytuo (lenacapavir)-the company's twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to reduce the...
50% US Tariff Comes Into Effect: Rs 5.4 Lakh Crore Indian Exports at Risk, Jobs and Sectors Under Pressure
Punekar News
·
August 27, 2025
New Delhi, 27th August 2025: Starting today, a steep 50% tariff has come into force on goods exported from India to the United States, dealing a heavy blow to Indian industries that rely on the American market. According to the Global Trade...
European Commission approves twice-yearly HIV injection lenacapavir, paving way
Mid Day Mumbai
·
August 27, 2025
The European Commission approves lenacapavir, a twice-yearly HIV prevention injection, for rollout across the EU. Sold as Yeytuo, it offers a breakthrough alternative to daily PrEP, addressing rising HIV cases across Europe. The European...
The Digital Shift: Redefining Insurance with Smarter Payments
Banking Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
European Commission Greenlights UM171 Cell Therapy for Hematologic Malignancies
OncLive
·
August 27, 2025
The European Commission has granted conditional approval to UM171 cell therapy (Zemcelpro) for the treatment of patients with hematologic malignancies who require allogeneic hematopoietic stem cell transplantation (HSCT) after myeloablative...
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
The AI Journal
·
August 26, 2025
– Yeytuo® is the First and Only European Commission (EC)-Authorized HIV PrEP Option Offering 6 Months of Protection – – Accelerated EC Decision Comes After U.S. FDA Approval in June – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc....
World News | European Commission Approves Twice-yearly HIV Injection Lenacapavir, Paving Way for EU Rollout
Latestly
·
August 27, 2025
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...
European Commission approves twice-yearly HIV injection lenacapavir, paving way for EU rollout
The Tribune (Chandigarh)
·
August 27, 2025
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...
The Mercury’s Sound Off for Wednesday, Aug. 27
The Mercury - Pennsylvania
·
August 27, 2025
Fair Districting? Representing 35% of the electorate, Massachusetts Republicans count zero members in the 9-person Congressional delegation. In California, Democrats, 45% of registered voters, hold 83% of Congressional seats (43-9). Similar...
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
Investor's Business Daily
·
August 26, 2025
Gilead Sciences (GILD) won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo. The approval comes two months after the Food and Drug Administration signed off on Yeztugo, the drug's branded name in the U.S....
Madrigal’s Rezdiffra Approved in EU for MASH Treatment
Pharma Journalist
·
August 20, 2025
Madrigal Pharmaceuticals, Inc. has received conditional marketing authorization from the European Commission (EC) for Rezdiffra (resmetirom), making it the first and only approved therapy in the European Union for adults with noncirrhotic MASH...
International business briefs: US hits Indian exports with 50% tariff
BusinessLIVE
·
Bengaluru —The European Commission has granted marketing authorisation for Gilead Sciences’ twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug, known scientifically as lenacapavir, will be sold in Europe...
Gilead secures EU approval for new HIV prevention injection
Brussels Morning
·
August 26, 2025
Brussels (Brussels Morning Newspaper) – On Tuesday, Gilead Sciences announced that the European Commission approved its semi-annual injection to prevent HIV infection, according to Reuters. Greenlight from the EU Commission applies in the EU’s 27...
EU approves Gilead’s new injection for preventing HIV
SRN News
·
August 26, 2025
Audio By Carbonatix By Deena Beasley (Reuters) -The European Commission has granted marketing authorization for Gilead Sciences’ twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug, known scientifically as...